SAN FRANCISCO – If there were any doubts that the drug pricing debate – exacerbated by recent political volleys – was a hot topic coming into this year BIO International Convention, they were surely dashed Tuesday afternoon during an increasingly animated fireside chat between recently named Celgene Corp. CEO Mark Alles and Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood.